Clinical Trials
63 trialsNCT05086250 2026-05-08
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Recruiting
NCT04665947 2026-04-29
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
University of California, Davis
Phase EARLY_PHASE1 Recruiting
NCT07089940 2026-03-23
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT04862260 2026-03-19
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
CHU de Quebec-Universite Laval
Phase EARLY_PHASE1 Active not recruiting
NCT07254091 2026-03-06
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
Northwell Health
Phase EARLY_PHASE1 Recruiting
NCT03164486 2026-02-27
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
University of California, Davis
Phase EARLY_PHASE1 Active not recruiting
NCT04005690 2026-02-27
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT06323291 2026-02-09
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT07394205 2026-02-06
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT07236177 2026-02-05
B-GLUCANCER2
Poitiers University Hospital
Phase EARLY_PHASE1 Recruiting
NCT04930991 2026-01-08
OU202005AJ
University of Oklahoma
Phase EARLY_PHASE1 Recruiting
NCT05336266 2026-01-06
KetoROCX
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Active not recruiting
NCT06496373 2025-11-17
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT07229768 2025-11-17
Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT05438667 2025-09-08
TCR-T Cell Therapy on Advanced Solid Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase EARLY_PHASE1 Recruiting
NCT05141643 2025-09-04
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04147494 2025-08-12
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07026981 2025-08-08
[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT03572283 2025-06-05
Bethanechol Prior to Pancreatic Surgery
Columbia University
Phase EARLY_PHASE1 Completed
NCT06122896 2025-06-03
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT06577532 2025-05-21
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT00902759 2025-05-02
Fatigue and Pancreas and Bile Duct Cancer Study
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT02896907 2025-04-30
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04048278 2025-03-03
Lidocaine Infusion in Pancreatic Cancer
University of Illinois at Chicago
Phase EARLY_PHASE1 Recruiting
NCT01821612 2025-01-13
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
Alliance for Clinical Trials in Oncology
Phase EARLY_PHASE1 Completed
NCT03153410 2025-01-09
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT06619886 2024-10-01
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT05482451 2024-08-21
Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer
China Medical University Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT04067960 2024-08-14
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03492164 2024-06-12
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT06326736 2024-03-22
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting
NCT03519308 2024-03-15
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT06196658 2024-01-09
Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer
First People's Hospital of Hangzhou
Phase EARLY_PHASE1 Not yet recruiting
NCT04870034 2023-12-22
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT06156267 2023-12-05
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
Fudan University
Phase EARLY_PHASE1 Not yet recruiting
NCT06054984 2023-10-13
GB3010-02
Ruijin Hospital
Phase EARLY_PHASE1 Unknown
NCT02683824 2023-09-21
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
Stanford University
Phase EARLY_PHASE1 Completed
NCT05875753 2023-05-25
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT05583201 2023-02-08
NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT01371240 2022-06-16
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
University Hospitals Cleveland Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT04966143 2021-07-19
Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer
Shanghai Longyao Biotechnology Inc., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03536208 2021-03-25
Biological Effect of Warfarin on Pancreatic Cancer
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT03718650 2021-02-08
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Withdrawn
NCT01715142 2020-09-04
NEOPAX-001
Erasme University Hospital
Phase EARLY_PHASE1 Completed
NCT03600623 2020-08-18
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
University of Alabama at Birmingham
Phase EARLY_PHASE1 Terminated
NCT02153450 2020-06-26
Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT00414570 2019-08-28
An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs
AHS Cancer Control Alberta
Phase EARLY_PHASE1 Terminated
NCT03481920 2019-08-22
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer
PH Research, S.L.
Phase EARLY_PHASE1 Terminated
NCT01992705 2019-08-19
GCC 1324
University of Maryland, Baltimore
Phase EARLY_PHASE1 Completed